Data is not available at this time.
Anhui Jinhe Industrial operates as a specialized chemical producer with a diversified portfolio spanning food additives, bulk chemicals, pharmaceutical intermediates, and functional chemicals. The company has established a vertically integrated manufacturing approach, producing core ingredients like acesulfame potassium sweeteners while also manufacturing essential industrial chemicals such as liquid ammonia and hydrogen peroxide. This dual focus allows Jinhe to serve both consumer-facing industries like food and beverage manufacturing and industrial sectors including coatings, resins, and agricultural chemicals. The company's market position is strengthened by its comprehensive product range that serves multiple end markets including food and beverage, daily consumption products, pharmaceutical manufacturing, and agricultural environmental protection. Founded in 1974, Jinhe has developed deep technical expertise across chemical synthesis processes, particularly in furan and pyridine chemistry, which supports its production of specialized intermediates. The company's headquarters in Chuzhou provides strategic access to China's eastern industrial regions, supporting its distribution network across domestic and international markets. Jinhe's business model combines scale production of commodity chemicals with higher-margin specialty products, creating a balanced revenue stream that leverages both volume-driven and value-added market segments within the chemical industry.
The company reported revenue of CNY 5.30 billion for the period, with net income reaching CNY 556.7 million, translating to a net margin of approximately 10.5%. Operating cash flow generation was robust at CNY 750.4 million, though significant capital expenditures of CNY 1.13 billion indicate substantial ongoing investment in production capacity and operational infrastructure. The diluted EPS of CNY 1.01 reflects efficient earnings distribution across the outstanding share base.
Jinhe demonstrates solid earnings power with CNY 556.7 million in net income, supported by strong operating cash flow generation that exceeds net income. The company's capital allocation strategy appears focused on growth, evidenced by capital expenditures that substantially exceed operating cash flow. This indicates a commitment to expanding production capabilities and maintaining competitive positioning within the chemical manufacturing sector.
The company maintains a conservative financial structure with CNY 2.00 billion in cash and equivalents against total debt of CNY 1.03 billion, providing substantial liquidity coverage. This cash-rich position, combined with moderate leverage, suggests strong financial flexibility to weather industry cycles and pursue strategic investments. The balance sheet structure supports ongoing operational requirements while maintaining capacity for potential expansion initiatives.
The company has demonstrated a shareholder-friendly approach through a dividend per share of CNY 0.83, representing a substantial payout relative to earnings. This dividend policy, combined with significant capital investment in production facilities, suggests a balanced strategy of returning capital to shareholders while funding growth initiatives. The company's focus on multiple chemical segments provides diversification benefits that may support stable growth across economic cycles.
With a market capitalization of approximately CNY 12.32 billion, the company trades at a P/E ratio of around 22 times trailing earnings, reflecting market expectations for continued growth in the specialty chemicals sector. The beta of 0.716 indicates lower volatility compared to the broader market, suggesting investor perception of relatively stable business fundamentals within the chemical manufacturing industry.
Jinhe's strategic advantages include its long-established operational history, diversified chemical portfolio, and vertical integration capabilities. The company's focus on both commodity and specialty chemicals provides resilience against sector-specific downturns. The outlook appears supported by ongoing demand from food, pharmaceutical, and industrial end-markets, though the company faces typical chemical industry challenges including raw material price volatility and regulatory requirements across its global operations.
Company financial reportsShenzhen Stock Exchange disclosures
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |